Top Preclinical Cro Companies in Norway

LINK Medical is a prominent contract research organization (CRO) with a strong focus on regulatory support and a commitment to enhancing the product development journey for pharmaceutical and medical device industries. They offer strategic partnerships that assess risks and streamline the pathway to market, making them well-equipped to handle preclinical and clinical development processes.

Curida Diatec is a biotechnology company with extensive experience in antibody production and conjugation, which may be relevant for preclinical research involving antibodies. Their commitment to quality, with production facilities adhering to ISO 9001 and GMP standards, ensures high-quality products that could be beneficial for preclinical applications.

There has been a significant increase in the number of studies managed by CROs in Norway, highlighting the growing role of contract research organizations in the region. This trend is supported by innovative research from the University of Oslo and Oslo University Hospital, which recently published findings on engineered human albumin variants that could enhance drug delivery and efficacy.

Cryogenetics specializes in developing cryopreservation protocols to enhance the reproduction potential of aquatic species, particularly Atlantic salmon. They provide tailored services and innovative technologies to optimize egg production and support conservation efforts through genetic preservation.

MCG Professionals offers a comprehensive range of resourcing services, including project consultancy and talent solutions, which could be valuable in preclinical research settings. Their focus on providing interim resource support ensures that organizations can maintain continuity and meet critical project needs effectively.

BioInvent is a clinical-stage company focused on discovering and developing innovative antibody-based immunotherapies for cancer, particularly targeting hematological cancers and solid tumors. Their robust pipeline and strategic partnerships position them well in the expanding market for cancer immunotherapy.

SERO AS is a biotechnology company specializing in the manufacture of quality control materials for laboratories, with extensive experience in areas such as immunoassay and clinical chemistry.

Preferred Global Health (PGH) is dedicated to improving outcomes for patients with critical illnesses, offering specialized medical services and care management from top-ranked hospitals in the US. With over 20 years of experience, PGH ensures patients receive expert advocacy and personalized support throughout their recovery journey.

ClexBio is a pre-clinical stage regenerative medicine company that focuses on innovative tissue generation using advanced microfluidics and proprietary hydrogel technology. Their expertise in cell biology and tissue culture automation positions them at the forefront of developing scalable solutions for tissue engineering.

SmithMED is a family-owned company with extensive experience in the pharmaceutical sector, dedicated to improving health through innovative diagnostic solutions. They offer CHROMagar products for detecting antibiotic-resistant bacteria and other microbes, which aligns with their mission to address health issues effectively.